Accuray Inc (ARAY)
1.93
+0.14
(+7.82%)
USD |
NASDAQ |
Nov 05, 16:00
1.93
0.00 (0.00%)
After-Hours: 16:07
Accuray Research and Development Expense (Annual): 49.73M for June 30, 2024
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | 49.73M |
| June 30, 2023 | 57.13M |
| June 30, 2022 | 57.75M |
| June 30, 2021 | 52.73M |
| June 30, 2020 | 49.78M |
| June 30, 2019 | 56.49M |
| June 30, 2018 | 57.25M |
| June 30, 2017 | 49.92M |
| June 30, 2016 | 56.65M |
| June 30, 2015 | 55.75M |
| June 30, 2014 | 53.72M |
| Date | Value |
|---|---|
| June 30, 2013 | 66.20M |
| June 30, 2012 | 81.29M |
| June 30, 2011 | 41.30M |
| June 30, 2010 | 31.52M |
| June 30, 2009 | 35.99M |
| June 30, 2008 | 32.88M |
| June 30, 2007 | 26.78M |
| June 30, 2006 | 17.79M |
| June 30, 2005 | 11.66M |
| June 30, 2004 | |
| June 30, 2003 | 5.844M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
49.73M
Minimum
2024
57.75M
Maximum
2022
53.43M
Average
52.73M
Median
2021
Research and Development Expense (Annual) Benchmarks
| Boston Scientific Corp | 1.414B |
| Baxter International Inc | 667.00M |
| AngioDynamics Inc | 31.51M |
| Masimo Corp | 175.20M |
| Perspective Therapeutics Inc | 21.31M |